Xi'an International Medical Investment Company Limited (SHE:000516)
China · Delayed Price · Currency is CNY 4.660
+0.030 (0.65%)
May 8, 2026, 3:04 PM CST
SHE:000516 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,047 | 4,075 | 4,741 | 4,506 | 2,662 | 2,901 |
Other Revenue | - | - | 74.31 | 111.85 | 48.47 | 20.62 |
| 4,047 | 4,075 | 4,815 | 4,618 | 2,711 | 2,921 | |
Revenue Growth (YoY) | -12.78% | -15.39% | 4.28% | 70.34% | -7.20% | 81.78% |
Cost of Revenue | 3,666 | 3,738 | 4,389 | 4,200 | 2,913 | 2,891 |
Gross Profit | 381.01 | 336.41 | 426.31 | 418.28 | -201.57 | 30.23 |
Selling, General & Admin | 552.51 | 570.01 | 548.11 | 646.85 | 632.67 | 656.76 |
Research & Development | 7.8 | 7.63 | 6.99 | 9.81 | 15.51 | 12.8 |
Other Operating Expenses | 58.08 | 58.91 | 61.54 | 68.82 | 38.61 | 28.6 |
Operating Expenses | 618.39 | 636.55 | 622.39 | 741.03 | 693.73 | 704.09 |
Operating Income | -237.38 | -300.14 | -196.08 | -322.75 | -895.3 | -673.87 |
Interest Expense | - | - | -173.35 | -219.03 | -190.53 | -190.77 |
Interest & Investment Income | 16.46 | 33.96 | 7.96 | 81.27 | 28.94 | 59.87 |
Currency Exchange Gain (Loss) | - | - | - | 1.12 | -3.7 | 0.43 |
Other Non Operating Income (Expenses) | -116.68 | -125.91 | -10.26 | -13.03 | -7.51 | -5.59 |
EBT Excluding Unusual Items | -337.59 | -392.1 | -371.74 | -472.42 | -1,068 | -809.93 |
Gain (Loss) on Sale of Investments | -0.3 | -5.98 | 23.77 | 2.1 | -80.79 | -104.36 |
Gain (Loss) on Sale of Assets | 0.18 | 0.18 | 1.66 | 1.95 | 7.25 | -0.17 |
Asset Writedown | -3.04 | -2.4 | -2.59 | -0.87 | -3.36 | -1.9 |
Other Unusual Items | - | - | 4.26 | 1.99 | 4.69 | -3.21 |
Pretax Income | -340.76 | -400.3 | -344.64 | -467.25 | -1,140 | -919.57 |
Income Tax Expense | 20.98 | 20.73 | 20.5 | 4.69 | 55.03 | -74.43 |
Earnings From Continuing Operations | -361.74 | -421.03 | -365.14 | -471.95 | -1,195 | -845.14 |
Minority Interest in Earnings | 106.68 | 107.95 | 111.01 | 103.59 | 18.66 | 22.97 |
Net Income | -255.06 | -313.08 | -254.13 | -368.36 | -1,177 | -822.17 |
Net Income to Common | -255.06 | -313.08 | -254.13 | -368.36 | -1,177 | -822.17 |
Shares Outstanding (Basic) | 2,231 | 2,236 | 2,255 | 2,302 | 2,263 | 2,222 |
Shares Outstanding (Diluted) | 2,231 | 2,236 | 2,255 | 2,302 | 2,263 | 2,222 |
Shares Change (YoY) | -3.39% | -0.83% | -2.06% | 1.74% | 1.84% | -2.03% |
EPS (Basic) | -0.11 | -0.14 | -0.11 | -0.16 | -0.52 | -0.37 |
EPS (Diluted) | -0.11 | -0.14 | -0.11 | -0.16 | -0.52 | -0.37 |
Free Cash Flow | 1,126 | 1,014 | 461.38 | 324.66 | -726.51 | -1,203 |
Free Cash Flow Per Share | 0.51 | 0.45 | 0.20 | 0.14 | -0.32 | -0.54 |
Gross Margin | 9.41% | 8.26% | 8.85% | 9.06% | -7.43% | 1.03% |
Operating Margin | -5.87% | -7.37% | -4.07% | -6.99% | -33.02% | -23.07% |
Profit Margin | -6.30% | -7.68% | -5.28% | -7.98% | -43.41% | -28.15% |
Free Cash Flow Margin | 27.82% | 24.89% | 9.58% | 7.03% | -26.80% | -41.20% |
EBITDA | 445.95 | 387.89 | 510.78 | 447.14 | -274.98 | -105.23 |
EBITDA Margin | 11.02% | 9.52% | 10.61% | 9.68% | -10.14% | -3.60% |
D&A For EBITDA | 683.33 | 688.03 | 706.86 | 769.89 | 620.31 | 568.64 |
EBIT | -237.38 | -300.14 | -196.08 | -322.75 | -895.3 | -673.87 |
EBIT Margin | -5.87% | -7.37% | -4.07% | -6.99% | -33.02% | -23.07% |
Revenue as Reported | - | - | 4,815 | 4,618 | 2,711 | 2,921 |
Advertising Expenses | - | - | 27.2 | 29.65 | 16.62 | 34.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.